It could do nothing. But even that didnt last long. Your best bet is to. Thats why they didnt change their recommendation when the Phase 3 trial was published in Lancet. More recently, hes adopted extremist positions on covid vaccines, which he alleges are toxic. He has claimed that one in 1,000 people who have received mRNA vaccines have died as a result, and even claimed the vaccines kill more people than they save at an FDA public forum, which was first reported by the Daily Beast. Hes also publicly railed against what he claims is a campaign against drugs like fluvoxamine and ivermectin. The U of M's study focused on three common drugs: ivermectin, metformin, and fluvoxamine. Their willingness to lie did. MD, MPH; Steven C. Marcus, PhD. Telling the truth, he tweeted. Why the FDA should grant an EUA for fluvoxamine immediately, Links to evidence about fluvoxamine including the public data repository, Here's the first one: To date, the #1 drug with the most evidence to make a significant difference, without any doubt, is fluvoxamine. Also, for people who cant tolerate fluvoxamine for whatever reason (nausea, jittery, etc), this is the alternative. By Steve Kirsch Mar 14, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful. MisinformationKills. A Cross-Sectional Study on the Personality Traits of Episodic and If you wanna find someone to debate me for ten thousand dollars, or a thousand dollars, Im happy to do that, just for your benefit.. All can merit a fluvoxamine prescription based on traditional diagnoses. Always be self aware when using fluvoxamine. Steve Kirsch (@stkirsch) / Twitter - Twitter. It's what's happening It was recommended back in January 2021 by a key opinion leader (KOL) panel to be used, but it took a year for, because they were rejected by 10 journals. So instead of this paper being treated as confirming an earlier hypothesis, it was treated as generating a novel hypothesis. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. He told me that while he and his family got vaccinated as soon as they were eligible, he got the idea that vaccines are dangerous from a man he hired to clean his carpets, who got very sick after receiving the vaccine. If you cant lay off the java, then try fluoxetine (Prozac). So far, doctors have failed to share his sense of urgency. Fluvoxamine data for COVID-19 Treatment - COVID-19 Early Treatment Fund YouTube , , , fluvoxamine, , , , , , , , , , People are dying because of physician fear of a new treatment with a 100% success rate and a solid mechanism of action. Doctors wait for government permission (EUA or added to the NIH guidelines) before using a drug. According to its founder, serial tech entrepreneur Steve Kirsch, CETF was started in April 2020 in order to fund. This is what the Seftel trial at Golden Gate fields used. In some cases, youd want to taper down the dosage. How I recommend people treat COVID and the fascinating backstory of how fluvoxamine was discovered. But how many did it help? skirsch.io Steve Kirsch Home page We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. So probability of successful Phase 3 can be estimated to be over 99.99% since there are tens of thousands of phase 3 studies. Steve Kirsch: Vaccine Killing Millions, Treatments, VAERS, 5-Month Death Signal, Mystery Clots Embed 7.76K 31 'This Has Cost Millions Of Lives': Steve Kirsch On Suppression Of Repurposed Drugs And A Spike In Deaths 5 Months After Vaccine Rollout By Jan Jekielek American Thought Leaders / The Epoch Times November 24, 2022 Show more This give another 50% of benefit. Thats pretty typical, but your mileage may vary. It is very safe: There is no evidence fluvoxamine is harmful and led to a worse outcome. As trial results rolled in, that mismatch began to put a strain on Kirschs relationship with the funds advisory board. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital security (OneID), or e-commerce (Propel Software). The NIH Guidelines committee is being very slow to react (we have no idea if they are even considering the drug because nobody is allowed to know that because all their deliberations are kept secret). I fully expected both organizations to do absolutely nothing. They were all given the drug soon after symptoms and the placebo group was pure in that they were not taking any COVID drugs. Decreasing the dosage or stopping the medication will mitigate symptoms within hours. vocus The NIH wrote a bullshit rejection because the FDA told them not to approve it. Fluvoxamine for early treatment of covid-19 - Medical Update Online Is that really true? These people never called the researchers whose trials they claimed showed no effect. The man who ran Risperdal sales, Alex Gorsky, is now CEO of Johnson & Johnson. Steve Kirsch is a high-tech serial entrepreneur based in Silicon Valley. I think so. In the early days of the pandemic, as billions of dollars poured into the hunt for novel treatments and vaccines, veteran Silicon Valley entrepreneur Steve Kirsch did what hes always done: He went looking for an underdog. BOMBSHELL: Top biostats professor admits we have NO CLUE # of people KILLED by COVID vaccines, he wrote. 36m "We found Fauci was the most highly compensated federal employee. If you were drowning and we had no known standard of care to save your life and someone had a life preserver which worked 160 times in a row, should we throw them the life preserver or let them drown because we aren't absolutely sure the life preserver's benefit > risk (since just because it worked 160 times in a row and there is a 99.99% chance the effect didn't happen by chance, we could have just gotten lucky). Nobody who took the drug got sick at all, most all wanted to return to work within 3 days after starting treatment. There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. It was tested in coronavirus patients because fluvoxamine has very strong anti-inflammatory properties. Steve Kirsch cut the check, which allowed Dr. Lenze to finish recruiting the 152 patients he needed for his trial. CETF founder Steve Kirsch accepted an invitation to discuss the findings on a weekly . Kirsch said that his attempts to promote fluvoxamine are being curtailed. This is a more comprehensive look at the key evidence supporting fluvoxamine: Hear from the doctors who did the studies directly as well as the Dean of Medicine at Emory University: List of the best evidence-based COVID treatment options. Get your prescription in advance of getting COVID. Steve Kirsch: Don't Get the Vax! Early Treatment Saves Lives No long haul symptoms if you start the drug ASAP after first symptoms. Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Flavio Cadegiani and Steve Kirsch's studies didn't make the cut. Their It has shown to be 100% protective of hospitalization in 2 clinical trials. That trial has now been completed, and the researchers are analyzing their data. Generally, at 50mg BID x 14, it is very tolerable as long as the patient is instructed to lay off the caffeine. I also think it makes a lot of sense to look for pre-existing drugs that can help treat covid symptoms. One of the first CETF grants was to investigate the antimalarial hydroxychloroquine. Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. . Can I see your risk-benefit analysis?. 33. His appearance on an episode of anti-covid-vaccine, pro-ivermectin pundit Bret Weinsteins DarkHorse podcast, alongside Robert Malone, a prominent source of vaccine misinformation, introduced Kirsch to followers of the intellectual dark web, who have since embraced him as a fellow truth-teller. The NIH never did a risk benefit analysis of this drug. Thats pretty typical, but your mileage may vary. It should be crystal clear to everyone that the current CDC guidelines for treating COVID aren't working. Or just depression about the vaccine mandates? Note that some of these articles are inaccurate. Fluvoxamine is a very safe drug on market for 37 years, tens of millions of people have taken it, no record in scientific literature of anyone dying on overdose, and according to doctors that know the drug the best, about as dangerous as taking a Tylenol. Doing something is better than nothing. For example, tylenol+caffeine+fluvoxamine can lead to serotonin syndrome. Fluvoxamine: A Review of Its Mechanism of Action and Its Role - PubMed In September, he resigned as CEO and gave up his board seat. In a recent post, discussing claims Kirsch made during a three-minute comment at an FDA public forum, Morris wrote: In spite of many pages of writing and claims of over a dozen independent analyses verifying their results, their evidence falls far short of substantiating these dramatic conclusions, including a claim that vaccines have caused >250K excess deaths in the USA.. Seftel was able to duplicate the 100% protection from hospitalization and death in the treatment group, vs. a 12.5% hospitalization/death rate for the No treatment group. Are the Covid-19 vaccines "safe and effective"? - TrialSiteNews He was recently featured on 60 Minutes which highlighted his . See this Wall Street Journal op-ed. Nobody in the medical community is speaking out about how hypocritical the medical community is for ignoring the positive Phase 3 trial results and instead following whatever the NIH or FDA says. Since FLV is a safe drug, it should have been widely discussed with patients that there is virtually no downside and a huge reduction in hospitalization if the drug is given early. Steve Kirsch is an inventor of the optimal mouse, a Silicon Valley millionaire, and an MIT alum (Class of '80). His foundation shifted focus to one goalcuring Steve Kirschby supporting one of the few scientists looking at the disease. What happens when your prescription drug becomes the center of covid misinformation. He was recently featured on 60 Minutes, . Fluvoxamine: The evidence - Steve Kirsch Home page Nov 12: Steve Kirsch gives talk on CETF to HarvardBusiness School hosted by Dr. Seftel Nov 13:Mass COVID outbreak at GGF is now publiclyknown Nov 16: Seftel, the track physician at GGF, startsFLV . People are dying. Im taking low dosage Fluvoxamine as part of a multi-drug FLCCC protocol to alleviate some mild brain fog. Most doctors wont use it until NIH greenlights it, no matter what the science says. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. If not, they should at least acknowledge that fluvoxamine might be helpful by at least listing it as a possibility. He started a covid-19 vaccine company. He says that Facebook took down one of his posts announcing his appearance on 60 Minutes. Its board told him that if he wanted to remain part of the company he would have to stop making public anti-vaccine statements. Yes, these were successes, but the successes could have been bigger if we had really paid attention to marketing. We report a real-world experience using fluvoxamine for coronavirus disease 19 (COVID-19) in a prospective cohort in the setting of a mass outbreak. The reason is pure corruption. He pushes fluvoxamine, an anti-depression drug which despite doing very well in covid treatment studies has been strangely neglected. Jan 17. Should you get vaccinated? Steve Kirsch | TrialSite News NIH is still unsure whether fluvoxamine should be used to treat COVID (article I did after the TOGETHER trial). ICER Publishes Final Evidence Report and Policy Recommendations on Outpatient Treatments for COVID-19 - ICER. reach out to us at We asked Steve to tone it down. Dr. Seftel's paper has been accepted for publication and will appear in OFID in early February. One Silicon Valley entrepreneur thought he could beat the odds. Medicine has been transformed to doing whatever the NIH/FDA says, regardless of how many lives will be lost. The documents in the data room discuss all eight (you'll need access to the restricted area to see the presentation on all 8). He has a history of giving away some of his millions to good causes, and when COVID-19 began. . And FrameMaker is still a niche product. He has a BS/MS in Electrical Engineering and Computer Science from MIT.